Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- MetroHealth Medical Center
- Study ID
- NCT05626816
- Status
- Recruiting
Conditions
- Fecal Incontinence
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Genital Nerve Stimulation — DEVICEElectrical stimulation applied to the genital nerve with surface electrodes using an off the shelf TENS unit (Ultima Plus). First, an amplitude threshold for the pudendo-anal reflex responses will be determined. Then, sham (1-2 Hz) and effective stimulation (20 Hz) will be briefly applied to record responses. Then, stimulation will be applied in random presentation order to record any changes in anorectal manometry outcomes due to both sham and effective stimulation.
- Clinical exam — DIAGNOSTIC_TESTExamination by physician determines the presence of pelvic reflexes (pudendo-anal and bulbocavernosus) which are essential for GNS to have an effect.
- Collection of SCI common data elements — DIAGNOSTIC_TESTData regarding participant demographics, history of injury, and medical history will be collected.
- Bowel function survey completion — DIAGNOSTIC_TESTTwo surveys will be conducted to assess the bowel function of the participant. The International SCI Bowel Function Basic Data Set (ISCI BF BDS v2.1) and the SCI Qulaity of Life Bowel Management Difficulties (SCI-QoL BMD) survey scales collect data on overall bowel function and how any difficulties impact the participants quality of life.
- International Standard for Neurological Classification of SCI (ISNCSCI) — DIAGNOSTIC_TESTThe physician will conduct the ISNCSCI to determine the level and severity of injury to the spinal cord. This is done by determining the ability to detect light touch and pinprick stimulation. Outcomes will be a Spinal Injury Association Impairment Scale (AIS) grade of A-D.
- Response to genital nerve stimulation (GNS) — DIAGNOSTIC_TESTGNS will be applied to determine if there is a response in the participant. If the participant has no response to the stimulation they will be excluded from the second visit as it is dependent on the ability to respond to GNS.
- Anorectal Manometry testing (ARM) — DIAGNOSTIC_TESTThe participant will be instrumented for ARM testing. This requires a special balloon catheter to be inserted into the anus and secured, surface electrode pads being applied to the anal sphincter, and electrode pads being applied to the genital nerve stimulation sites. Once instrumented, the participant will be tested with the London Classification procedure. This procedure asks the participant to perform several actions (squeeze to withhold a bowel movement, push to have a bowel movement, and cough) as well as inflating the balloon on the catheter to determine reflex thresholds (RAIR, retroanal inhibitory reflex which relaxes the anal sphincter in response to rectal distension) and sensory thresholds (first senstation,
Study Details
Bowel issues occur in nearly all people after spinal cord injury (SCI) and one major complication is fecal incontinence (accidents). This complication has been repeatedly highlighted by people living with SCI as particularly life-limiting and in need of more options for interventions. This study will test the effect of genital nerve stimulation (GNS), with non-invasive electrodes, on the activity of the anus and rectum of persons after SCI. Recording anorectal manometry (ARM) endpoints tells us the function of those tissues and our study design (ARM without stim, ARM with stim, ARM without stim) will allow us to conclude the GNS effect and whether it is likely to reduce fecal incontinence. The study will also collect medical, demographic, and bowel related functional information. The combination of all of these data should help predict who will respond to stimulation, what will happen when stimulation is applied, and if that stimulation is likely to provide an improvement in fecal continence for people living with SCI.
Key Dates
- Start date
- Mar 21, 2023
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: All interventions, Sham applied firstThese participants will have all interventions applied, but will be randomly designated to have sham stimulation applied before effective stimulation. This will balance any issue with order of presentation of multiple stimulation sessions.
- Experimental: All interventions, effective stim applied firstThese participants will have all interventions applied, but will be randomly designated to have effective stimulation applied before sham stimulation. This will balance any issue with order of presentation of multiple stimulation sessions.
Primary Outcome Measure
ARM outcome - Rectal wall tension [ Time Frame: Up to three weeks after enrollment ]
Central Contacts
- Mayson Moore2169573558
- Rob Hoey, PhD2169573665
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MetroHealth Medical System Old Brooklyn Campus | Cleveland | Ohio | 44109 | Kim Anderson, PhD (PRINCIPAL_INVESTIGATOR) Rob Hoey, PhD (PRINCIPAL_INVESTIGATOR) Dennis Bourbeau, PhD (SUB_INVESTIGATOR) James Wilson, DO (SUB_INVESTIGATOR) Ronnie Fass, MD (SUB_INVESTIGATOR) Doug Gunzler, PhD (SUB_INVESTIGATOR) |
Find similar trials in Cleveland, OH
Related Studies
- Pelvic Health Electrically Evoked Recording (PEER) 2 StudyRecruiting · MedtronicNeuro · Indianapolis, Indiana
- Indiana University Gastrointestinal Motility Diagnosis RegistryRecruiting · Indiana University · Indianapolis, Indiana
- Autologous Muscle Fiber Fragment InjectionsRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)Recruiting · The California Medical Innovations Institute, Inc. · San Diego, California